Cargando…
Elevated CSF LRG and Decreased Alzheimer’s Disease Biomarkers in Idiopathic Normal Pressure Hydrocephalus
Leucine-rich-alpha-2-glykoprotein (LRG) is suggested as a potential biomarker for idiopathic normal pressure hydrocephalus (iNPH). Our goal was to compare the cerebrospinal fluid (CSF) LRG levels between 119 iNPH patients and 33 age-matched controls and with the shunt responses and the brain biopsy...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961420/ https://www.ncbi.nlm.nih.gov/pubmed/33800840 http://dx.doi.org/10.3390/jcm10051105 |
_version_ | 1783665256661254144 |
---|---|
author | Vanninen, Aleksi Nakajima, Madoka Miyajima, Masakazu Rauramaa, Tuomas Kokki, Merja Musialowicz, Tadeusz Mäkinen, Petra M. Herukka, Sanna-Kaisa Koivisto, Anne M. Jääskeläinen, Juha E. Hiltunen, Mikko Leinonen, Ville |
author_facet | Vanninen, Aleksi Nakajima, Madoka Miyajima, Masakazu Rauramaa, Tuomas Kokki, Merja Musialowicz, Tadeusz Mäkinen, Petra M. Herukka, Sanna-Kaisa Koivisto, Anne M. Jääskeläinen, Juha E. Hiltunen, Mikko Leinonen, Ville |
author_sort | Vanninen, Aleksi |
collection | PubMed |
description | Leucine-rich-alpha-2-glykoprotein (LRG) is suggested as a potential biomarker for idiopathic normal pressure hydrocephalus (iNPH). Our goal was to compare the cerebrospinal fluid (CSF) LRG levels between 119 iNPH patients and 33 age-matched controls and with the shunt responses and the brain biopsy Alzheimer’s disease (AD) pathology among the iNPH patients. CSF LRG, Aβ(1-42), P-tau(181), and T-tau were measured by using commercial ELISAs. The LRG levels in the CSF were significantly increased in the iNPH patients (p < 0.001) as compared to the controls, regardless of the AD pathology. However, CSF LRG did not correlate with the shunt response in contrast to the previous findings. The CSF AD biomarkers, i.e., Aβ(1-42), T-tau, and P-tau correlated with the brain biopsy AD pathology as expected but were systematically lower in the iNPH patients when compared to the controls (<0.001). Our findings support that the LRG levels in the CSF are potentially useful for the diagnostics of iNPH, independent of the brain AD pathology, but contrary to previous findings, not for predicting the shunt response. Our findings also suggest a need for specific reference values of the CSF AD biomarkers for the diagnostics of comorbid AD pathology in the iNPH patients. |
format | Online Article Text |
id | pubmed-7961420 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-79614202021-03-17 Elevated CSF LRG and Decreased Alzheimer’s Disease Biomarkers in Idiopathic Normal Pressure Hydrocephalus Vanninen, Aleksi Nakajima, Madoka Miyajima, Masakazu Rauramaa, Tuomas Kokki, Merja Musialowicz, Tadeusz Mäkinen, Petra M. Herukka, Sanna-Kaisa Koivisto, Anne M. Jääskeläinen, Juha E. Hiltunen, Mikko Leinonen, Ville J Clin Med Article Leucine-rich-alpha-2-glykoprotein (LRG) is suggested as a potential biomarker for idiopathic normal pressure hydrocephalus (iNPH). Our goal was to compare the cerebrospinal fluid (CSF) LRG levels between 119 iNPH patients and 33 age-matched controls and with the shunt responses and the brain biopsy Alzheimer’s disease (AD) pathology among the iNPH patients. CSF LRG, Aβ(1-42), P-tau(181), and T-tau were measured by using commercial ELISAs. The LRG levels in the CSF were significantly increased in the iNPH patients (p < 0.001) as compared to the controls, regardless of the AD pathology. However, CSF LRG did not correlate with the shunt response in contrast to the previous findings. The CSF AD biomarkers, i.e., Aβ(1-42), T-tau, and P-tau correlated with the brain biopsy AD pathology as expected but were systematically lower in the iNPH patients when compared to the controls (<0.001). Our findings support that the LRG levels in the CSF are potentially useful for the diagnostics of iNPH, independent of the brain AD pathology, but contrary to previous findings, not for predicting the shunt response. Our findings also suggest a need for specific reference values of the CSF AD biomarkers for the diagnostics of comorbid AD pathology in the iNPH patients. MDPI 2021-03-06 /pmc/articles/PMC7961420/ /pubmed/33800840 http://dx.doi.org/10.3390/jcm10051105 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Vanninen, Aleksi Nakajima, Madoka Miyajima, Masakazu Rauramaa, Tuomas Kokki, Merja Musialowicz, Tadeusz Mäkinen, Petra M. Herukka, Sanna-Kaisa Koivisto, Anne M. Jääskeläinen, Juha E. Hiltunen, Mikko Leinonen, Ville Elevated CSF LRG and Decreased Alzheimer’s Disease Biomarkers in Idiopathic Normal Pressure Hydrocephalus |
title | Elevated CSF LRG and Decreased Alzheimer’s Disease Biomarkers in Idiopathic Normal Pressure Hydrocephalus |
title_full | Elevated CSF LRG and Decreased Alzheimer’s Disease Biomarkers in Idiopathic Normal Pressure Hydrocephalus |
title_fullStr | Elevated CSF LRG and Decreased Alzheimer’s Disease Biomarkers in Idiopathic Normal Pressure Hydrocephalus |
title_full_unstemmed | Elevated CSF LRG and Decreased Alzheimer’s Disease Biomarkers in Idiopathic Normal Pressure Hydrocephalus |
title_short | Elevated CSF LRG and Decreased Alzheimer’s Disease Biomarkers in Idiopathic Normal Pressure Hydrocephalus |
title_sort | elevated csf lrg and decreased alzheimer’s disease biomarkers in idiopathic normal pressure hydrocephalus |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961420/ https://www.ncbi.nlm.nih.gov/pubmed/33800840 http://dx.doi.org/10.3390/jcm10051105 |
work_keys_str_mv | AT vanninenaleksi elevatedcsflrganddecreasedalzheimersdiseasebiomarkersinidiopathicnormalpressurehydrocephalus AT nakajimamadoka elevatedcsflrganddecreasedalzheimersdiseasebiomarkersinidiopathicnormalpressurehydrocephalus AT miyajimamasakazu elevatedcsflrganddecreasedalzheimersdiseasebiomarkersinidiopathicnormalpressurehydrocephalus AT rauramaatuomas elevatedcsflrganddecreasedalzheimersdiseasebiomarkersinidiopathicnormalpressurehydrocephalus AT kokkimerja elevatedcsflrganddecreasedalzheimersdiseasebiomarkersinidiopathicnormalpressurehydrocephalus AT musialowicztadeusz elevatedcsflrganddecreasedalzheimersdiseasebiomarkersinidiopathicnormalpressurehydrocephalus AT makinenpetram elevatedcsflrganddecreasedalzheimersdiseasebiomarkersinidiopathicnormalpressurehydrocephalus AT herukkasannakaisa elevatedcsflrganddecreasedalzheimersdiseasebiomarkersinidiopathicnormalpressurehydrocephalus AT koivistoannem elevatedcsflrganddecreasedalzheimersdiseasebiomarkersinidiopathicnormalpressurehydrocephalus AT jaaskelainenjuhae elevatedcsflrganddecreasedalzheimersdiseasebiomarkersinidiopathicnormalpressurehydrocephalus AT hiltunenmikko elevatedcsflrganddecreasedalzheimersdiseasebiomarkersinidiopathicnormalpressurehydrocephalus AT leinonenville elevatedcsflrganddecreasedalzheimersdiseasebiomarkersinidiopathicnormalpressurehydrocephalus |